Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue
The STEP-1 trial (N=1,961) demonstrated 14.9% mean body weight reduction over 68 weeks but the metabolic finding more directly relevant here is that HOMA-IR and fasting insulin dropped significantly beyond what weight loss alone would predict, suggesting a direct insulin-sensitising effect at the receptor and hepatic levels
Complete a quick and easy questionnaire from the comfort of your home
Martinez-Carrasco and Fini, 2023)
Although both of these index SNPs were in moderate linkage disequilibrium with the BMI-loss coding variant (rs11760106 versus rs10305420 r 2 = 0.57
Many counties in these regions have primary care shortages, and finding an in-person provider who prescribes semaglutide for weight management can involve long wait times or significant travel